Plasma levels of trefoil factors are increased in patients with advanced prostate cancer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Cancer Research |
Vol/bind | 12 |
Udgave nummer | 3 Pt 1 |
Sider (fra-til) | 807-812 |
Antal sider | 6 |
ISSN | 1078-0432 |
DOI | |
Status | Udgivet - 2006 |
ID: 1207944